How to make the best use of graphics
The power of a graph lies in its ability to convey a variety of complex relationships in a way that is difficult to describe in words, but is easily comprehended from a picture.
DetailsTop Tips for Creating Patient Education Material
Information is an important part of the patient journey and central to the overall quality of each patient’s experience with your drug, treatment or product. To help you get the best out of our free patient education material offer, we have created this blog post to help you identify what elements make good patient…
DetailsTop Ten Patient Education Websites
As part of FREE Patient Education Material offer we have written this post to showcase some of the best examples of patient education websites on the web to help you develop your own site. Please note that these are in no particular order. Patients Like Me Intuitive registration process Simple interface All the patient…
DetailsHealth Economics Professionals Collaborating with Medical Publications Professionals
We attended the 8th Annual ISMPP Meeting in April 2012 in Baltimore and asked attendees and speakers what they thought were the key motivations for health economics and outcomes researchers working together with medical publications professionals?
DetailsWhat Type of Collaborations are Emerging Within the Medical Publications Arena?
We attended the 8th Annual ISMPP Meeting in April 2012 in Baltimore and asked attendees and speakers What type of collaborative initiatives are currently emerging within the medical publications and pharmaceutical arena?
DetailsIs Regionalisation of Phase IV Trials a Good Thing?
Regionalisation of phase IV trials because of payer differences sounds like a good thing in the short term. Improved market access, for one. But has anyone considered the longer term effects?
DetailsCompetitive Intelligence and Competitor Strategy
Interesting article in PharmaVoice in April 2012 – regarding Competitive Intelligence and Competitor Strategy. The article rightly points out that Pharma is leaving good intel on the table –by not developing relationships and using them effectively; or by taking a very high-minded attitude to informal sources of intel (e.g. conversations overheard at airports); or with…
DetailsUsing euphemisms and jargon in health economics
As noted by our former editor, David Woods, euphemisms have been referred to as verbal placebos – a way of discussing unpleasant topics in a more palatable manner. But do euphemisms really change the way we think? And should Health economists be encouraged to use them when discussing their economics research of medical topics?
DetailsEvidence matters… of course it does!
Ruairi O’Donnell writes in the March 2012 issue of Pharmaceutical Market Europe that evidence matters. Of course it does. And particularly in market access activities, which is the context he addresses in his article. Some of the points he makes are very good: about payers as a group being a variety of different types of people…
DetailsAnatomy of a medical communications project manager
We thought we should provide some insight to the anatomy of our medical communications project manager
Details